- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on GM1 Gangliosidosis, Type 2
Total 9524 results
-
Bogomolets National Medical UniversityCompletedInsulin Resistance | Type2 Diabetes | Probiotic
-
Johns Hopkins UniversityBeth Israel Deaconess Medical CenterActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Diabetes | Diabetes type2 | Type 2 Diabetes | Type2 Diabetes | Type II Diabetes | High Blood PressureUnited States
-
Zhejiang Provincial People's HospitalNot yet recruitingType2 Diabetes | type1diabetesChina
-
Medtronic DiabetesCompletedType 1 Diabetes Mellitus | Type2 Diabetes MellitusUnited States
-
Beijing Friendship HospitalBeijing Tiantan Hospital; Taipei Medical University Hospital; The First Affiliated... and other collaboratorsRecruitingType2 Diabetes | Complication of Bariatric ProcedureChina
-
Kirsi PietiläinenTurku University Hospital; University of HelsinkiRecruitingType2 DiabetesFinland
-
Trisakti UniversityActive, not recruitingType2 Diabetes MellitusIndonesia
-
University Hospital, Gentofte, CopenhagenCompleted
-
Boston CollegeJoslin Diabetes CenterCompleted
-
Per-Ola CarlssonCompleted
-
Jeil Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes MellitusKorea, Republic of
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Sun Yat-sen UniversityThe First Affiliated Hospital with Nanjing Medical University; Guangdong Provincial... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
BayerActive, not recruiting
-
Shanghai HEP Pharmaceutical Co., Ltd.WithdrawnType 2 Diabetes Patients
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
Rush University Medical CenterWithdrawn
-
TheracosCompletedType 2 Diabetes MellitusGermany, United States, Spain, Poland
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Oramed, Ltd.IntegriumCompletedDiabetes Type 2United States
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany, United States
-
University of OxfordNIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)CompletedType 2 Diabetes MellitusUnited Kingdom
-
Kun-Ho YoonTakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of PalermoAstraZeneca; University of CataniaUnknown
-
LG Life SciencesCompleted
-
Biocon LimitedCompletedType 2 Diabetes Mellitus
-
Sun Yat-sen UniversitySuspended
-
Novartis PharmaceuticalsCompletedType-2 Diabetes MellitusHong Kong
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
NovartisCompleted
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
TakedaCompleted
-
HealthPartners InstituteAmylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
University of ArizonaUnknownType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
Poxel SACompletedType 2 Diabetes MellitusLatvia
-
Pusan National University HospitalUnknownType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Hospital Universitario Central de AsturiasSanofiTerminated
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Completed